相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes
Hongying Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer
Marketa Koleckova et al.
SCIENTIFIC REPORTS (2021)
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis
Behzad Mansoori et al.
GENES (2021)
Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer
Bo Gao et al.
FRONTIERS IN ONCOLOGY (2021)
Roles and Regulation of TET Enzymes in Solid Tumors
Julie K. Bray et al.
TRENDS IN CANCER (2021)
Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer
Jiwei Liu et al.
EMBO REPORTS (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Selective targeting of TET catalytic domain promotes somatic cell reprogramming
Anup Kumar Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Expression of H3K4me3 and H3K9ac in breast cancer
Luisa Berger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Identification of miRNA Master Regulators in Breast Cancer
Antonio Daniel Martinez-Gutierrez et al.
CELLS (2020)
Histone Acetyltransferase MOF Orchestrates Outcomes at the Crossroad of Oncogenesis, DNA Damage Response, Proliferation, and Stem Cell Development
Mayank Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2020)
Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer
Bin Bao et al.
MOLECULAR CANCER RESEARCH (2020)
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Antonio Marra et al.
NPJ BREAST CANCER (2020)
Recent evolution of a TET-controlled and DPPA3/STELLA-driven pathway of passive DNA demethylation in mammals (vol 11, pg 5972, 2020)
Christopher B. Mulholland et al.
NATURE COMMUNICATIONS (2020)
Identification of Novel MeCP2 Cancer-Associated Target Genes and Post-Translational Modifications
Isabel Castro-Piedras et al.
FRONTIERS IN ONCOLOGY (2020)
Histone Signatures Predict Therapeutic Efficacy in Breast Cancer
Shamim A. Mollah et al.
IEEE OPEN JOURNAL OF ENGINEERING IN MEDICINE AND BIOLOGY (2020)
Prognostic role of high TET1 expression in patients with solid tumors A meta-analysis
Qiwei Ke et al.
MEDICINE (2020)
Molecular subtypes of triple-negative breast cancer: understanding of subtype categories and clinical implication
Yong-Moon Lee et al.
GENES & GENOMICS (2020)
Comprehensive Proteomic Characterization Reveals Subclass-Specific Molecular Aberrations within Triple-negative Breast Cancer
Max Kosok et al.
ISCIENCE (2020)
TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target
Lin-Yu Chen et al.
JOURNAL OF PATHOLOGY (2019)
Cytosine-Based TET Enzyme Inhibitors
Gabriella N. L. Chua et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging
Leo Phillips et al.
FRONTIERS IN ONCOLOGY (2019)
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Woonbok Chung et al.
CLINICAL EPIGENETICS (2019)
Refinement of breast cancer molecular classification by miRNA expression profiles
Rolf Sokilde et al.
BMC GENOMICS (2019)
DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs
Jie Yu et al.
DRUG DISCOVERY TODAY (2019)
The Immune Landscape of Cancer (vol 48, pg 812, 2018)
Vesteinn Thorsson et al.
IMMUNITY (2019)
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Hao-Xiang Wu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
Mohammad Mijanur Rahman et al.
CELLS (2019)
p53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer
Piotr T. Filipczak et al.
CANCER RESEARCH (2019)
Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells
Emily A. Teslow et al.
MOLECULAR ONCOLOGY (2019)
Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
Yong Yu et al.
THERANOSTICS (2019)
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
Charly Ryan Good et al.
CANCER RESEARCH (2018)
alpha-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis
Sandra Atlante et al.
CELL DEATH & DISEASE (2018)
Immunity drives TET1 regulation in cancer through NF-κB
Evelyne Collignon et al.
SCIENCE ADVANCES (2018)
The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
Daiana Cosmina Temian et al.
JOURNAL OF BREAST CANCER (2018)
TET2 coactivates gene expression through demethylation of enhancers
Lu Wang et al.
SCIENCE ADVANCES (2018)
A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1
Naifei Chen et al.
GENOME BIOLOGY (2018)
Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia
Gail J. Roboz et al.
CANCER (2018)
TET2 binds the androgen receptor and loss is associated with prostate cancer
M. L. Nickerson et al.
ONCOGENE (2017)
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Hagop M. Kantarjian et al.
LANCET ONCOLOGY (2017)
TET-mediated active DNA demethylation: mechanism, function and beyond
Xiaoji Wu et al.
NATURE REVIEWS GENETICS (2017)
A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer
Charly R. Good et al.
NUCLEIC ACIDS RESEARCH (2017)
MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells
Hua Wang et al.
ONCOTARGET (2017)
DNA Hypomethylating Drugs in Cancer Therapy
Takahiro Sato et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Isoform Switch of TET1 Regulates DNA Demethylation and Mouse Development
Wenhao Zhang et al.
MOLECULAR CELL (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Targeting the cancer epigenome for therapy
Peter A. Jones et al.
NATURE REVIEWS GENETICS (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers
Lili Li et al.
SCIENTIFIC REPORTS (2016)
Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation
Garth H. Rauscher et al.
BMC CANCER (2015)
Minimal role of base excision repair in TET-induced global DNA demethylation in HEK293T cells
Chunlei Jin et al.
EPIGENETICS (2015)
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Jean-Pierre J. Issa et al.
LANCET ONCOLOGY (2015)
Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells
Miao Sun et al.
MOLECULAR CELL (2015)
Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer
Liu Yang et al.
PLOS ONE (2015)
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
Clare Stirzaker et al.
NATURE COMMUNICATIONS (2015)
The Proteomic Landscape of Triple-Negative Breast Cancer (vol 11, pg 630, 2015)
Robert T. Lawrence et al.
CELL REPORTS (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
A DNA methylation-based definition of biologically distinct breast cancer subtypes
Olafur A. Stefansson et al.
MOLECULAR ONCOLOGY (2015)
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
F. Neri et al.
ONCOGENE (2015)
The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers
David A. Russler-Germain et al.
CANCER CELL (2014)
Nucleosome repositioning links DNA (de)methylation and differential CTCF binding during stem cell development
Vladimir B. Teif et al.
GENOME RESEARCH (2014)
TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells
Chunlei Jin et al.
NUCLEIC ACIDS RESEARCH (2014)
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
Myunggon Ko et al.
NATURE (2013)
DNA methylation: roles in mammalian development
Zachary D. Smith et al.
NATURE REVIEWS GENETICS (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells
Francesco Neri et al.
GENOME BIOLOGY (2013)
DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory
Noel J. -M. Raynal et al.
CANCER RESEARCH (2012)
Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development
Yufei Xu et al.
CELL (2012)
A complex Polycomb issue: the two faces of EZH2 in cancer
Hanno Hock
GENES & DEVELOPMENT (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Dnmt3a is essential for hematopoietic stem cell differentiation
Grant A. Challen et al.
NATURE GENETICS (2012)
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
Chih-Hung Hsu et al.
CELL REPORTS (2012)
DNA methylation signatures for breast cancer classification and prognosis
Moshe Szyf
GENOME MEDICINE (2012)
CpG islands and the regulation of transcription
Aimee M. Deaton et al.
GENES & DEVELOPMENT (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
Yu-Fei He et al.
SCIENCE (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito et al.
SCIENCE (2011)
Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
Fang Fang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases
Christoph Loenarz et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine
Haikuo Zhang et al.
CELL RESEARCH (2010)
Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids
Lakshminarayan M. Iyer et al.
CELL CYCLE (2009)
Targeting DNA Methylation
Jean-Pierre J. Issa et al.
CLINICAL CANCER RESEARCH (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites
A Hermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
